SCHEMBL23809137

SCHEMBL23809137

Cc1nn(CC2CCOCC2)c(C)c1C(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 1/20 0.38
SLC2A2 P11168 1/20 0.38
SLC2A3 P11169 1/20 0.38
NR3C1 P04150 1/20 0.35
CNR2 P34972 11/20 0.35
SLC16A3 O15427 1/20 0.35
SLC16A1 P53985 1/20 0.35
CNR1 P21554 3/20 0.33
PDE8B O95263 1/20 0.33
MEN1 O00255 1/20 0.32
MAPT P10636 1/20 0.32
RAB9A P51151 1/20 0.32
KMT2A Q03164 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
EED O75530 1/20 0.32
RBBP4 Q09028 1/20 0.32
SUZ12 Q15022 1/20 0.32
EZH2 Q15910 1/20 0.32
AEBP2 Q6ZN18 1/20 0.32
GBA1 P04062 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15445674 0.89 MAPT (0.35) CNR2CNR1MEN1MAPTRAB9A
SCHEMBL26037890 0.82 NR3C1 (0.35) NR3C1MEN1MAPTRAB9AKMT2A
SCHEMBL17943466 0.80 CNR1 (0.31) CNR2CNR1
SCHEMBL12335154 0.72 MEN1 (0.45) SLC2A1SLC2A2SLC2A3NR3C1PDE8B
SCHEMBL22304936 0.71 SLC16A3 (0.35) CNR2SLC16A3SLC16A1CNR1PDE8B
SCHEMBL13748881 0.71 GRM2 (0.37) CNR2CNR1MAPT
SCHEMBL284087 0.71 CNR2 (0.40) SLC2A1SLC2A2SLC2A3CNR2SLC16A3
SCHEMBL22304933 0.70 CNR2 (0.34) NR3C1CNR2SLC16A3SLC16A1CNR1
SCHEMBL21960869 0.68 L3MBTL1 (0.42) SLC2A1SLC2A2SLC2A3NR3C1CNR2
SCHEMBL24758178 0.68 NR3C1 (0.41) SLC2A1SLC2A2SLC2A3NR3C1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2021-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL9 SLC2A1 2589/4885SLC2A2 2806/4885SLC2A3 3272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.